Mucocutaneous manifestations of Epstein-Barr virus infection

This review focuses on Epstein-Barr virus (EBV) infection, diagnosis, and current treatment, with emphasis on EBV-associated mucocutaneous manifestations in primary infections, acute EBV-associated syndromes, chronic infections, lymphoproliferative disorders, and lymphomas. In primary infection, EBV...

Full description

Autores:
Mendoza, Natalia
Diamantis, Melissa
Arora, Anita
Bartlett, Brenda
Gewirtzman, Aron
Tremaine, Anne-Marie
Tyring, Stephen
Tipo de recurso:
Article of journal
Fecha de publicación:
2008
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
eng
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/4677
Acceso en línea:
http://hdl.handle.net/20.500.12495/4677
https://doi.org/10.2165/00128071-200809050-00003
https://repositorio.unbosque.edu.co
Palabra clave:
Síndrome mucocutáneo linfonodular
Epstein-Barr
Infecciones
Rights
openAccess
License
Acceso abierto
id UNBOSQUE2_ea25407c3b65a3cc8c77f8576cd35c18
oai_identifier_str oai:repositorio.unbosque.edu.co:20.500.12495/4677
network_acronym_str UNBOSQUE2
network_name_str Repositorio U. El Bosque
repository_id_str
dc.title.spa.fl_str_mv Mucocutaneous manifestations of Epstein-Barr virus infection
dc.title.translated.spa.fl_str_mv Mucocutaneous manifestations of Epstein-Barr virus infection
title Mucocutaneous manifestations of Epstein-Barr virus infection
spellingShingle Mucocutaneous manifestations of Epstein-Barr virus infection
Síndrome mucocutáneo linfonodular
Epstein-Barr
Infecciones
title_short Mucocutaneous manifestations of Epstein-Barr virus infection
title_full Mucocutaneous manifestations of Epstein-Barr virus infection
title_fullStr Mucocutaneous manifestations of Epstein-Barr virus infection
title_full_unstemmed Mucocutaneous manifestations of Epstein-Barr virus infection
title_sort Mucocutaneous manifestations of Epstein-Barr virus infection
dc.creator.fl_str_mv Mendoza, Natalia
Diamantis, Melissa
Arora, Anita
Bartlett, Brenda
Gewirtzman, Aron
Tremaine, Anne-Marie
Tyring, Stephen
dc.contributor.author.none.fl_str_mv Mendoza, Natalia
Diamantis, Melissa
Arora, Anita
Bartlett, Brenda
Gewirtzman, Aron
Tremaine, Anne-Marie
Tyring, Stephen
dc.subject.decs.spa.fl_str_mv Síndrome mucocutáneo linfonodular
Epstein-Barr
Infecciones
topic Síndrome mucocutáneo linfonodular
Epstein-Barr
Infecciones
description This review focuses on Epstein-Barr virus (EBV) infection, diagnosis, and current treatment, with emphasis on EBV-associated mucocutaneous manifestations in primary infections, acute EBV-associated syndromes, chronic infections, lymphoproliferative disorders, and lymphomas. In primary infection, EBV infects B cells and can cause mucocutaneous manifestations in infectious mononucleosis or acute EBV-associated syndromes such as Gianotti-Crosti syndrome and hemophagocytic syndrome. EBV then persists in the majority of humans generally without causing disease. In some cases, however, latent EBV infection may result in diseases such as hydroa vacciniforme, hypersensitivity to mosquito bites, and lymphoproliferative disorders such as plasmablastic lymphoma, oral hairy leukoplakia, and post-transplant lymphoproliferative disorders, particularly in immunocompromised patients. Latent EBV infection has also been implicated in a variety of malignant conditions such as Burkitt lymphoma, Hodgkin lymphoma, nasopharyngeal carcinoma, and Kikuchi histocytic necrotizing lymphadenitis. Since the immune system is critical in preventing the progression of EBV disease, the immunologic status of the patient plays a crucial role in the subsequent development of pathologies.
publishDate 2008
dc.date.issued.none.fl_str_mv 2008
dc.date.accessioned.none.fl_str_mv 2020-11-11T20:11:59Z
dc.date.available.none.fl_str_mv 2020-11-11T20:11:59Z
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.local.none.fl_str_mv Artículo de revista
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
format http://purl.org/coar/resource_type/c_6501
dc.identifier.issn.none.fl_str_mv 1179-1888
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/20.500.12495/4677
dc.identifier.doi.none.fl_str_mv https://doi.org/10.2165/00128071-200809050-00003
dc.identifier.instname.spa.fl_str_mv instname:Universidad El Bosque
dc.identifier.reponame.spa.fl_str_mv reponame:Repositorio Institucional Universidad El Bosque
dc.identifier.repourl.none.fl_str_mv https://repositorio.unbosque.edu.co
identifier_str_mv 1179-1888
instname:Universidad El Bosque
reponame:Repositorio Institucional Universidad El Bosque
url http://hdl.handle.net/20.500.12495/4677
https://doi.org/10.2165/00128071-200809050-00003
https://repositorio.unbosque.edu.co
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartofseries.spa.fl_str_mv American Journal of Clinical Dermatology, 1179-1888, Vol. 9, Nro. 5, 2008 p. 295-305
dc.relation.uri.none.fl_str_mv https://link.springer.com/article/10.2165/00128071-200809050-00003
dc.rights.local.spa.fl_str_mv Acceso abierto
dc.rights.accessrights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
Acceso abierto
dc.rights.creativecommons.none.fl_str_mv 2008
rights_invalid_str_mv Acceso abierto
http://purl.org/coar/access_right/c_abf2
2008
eu_rights_str_mv openAccess
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Springer Link
dc.publisher.journal.spa.fl_str_mv American Journal of Clinical Dermatology
institution Universidad El Bosque
bitstream.url.fl_str_mv http://18.204.144.38/bitstreams/8ef586ac-7162-4b4e-856b-6901da9e8908/download
http://18.204.144.38/bitstreams/cd8b509a-46cf-40ff-8265-a3139053ce3e/download
http://18.204.144.38/bitstreams/b77b26bc-93a9-4785-ad9f-479bb8f52b16/download
http://18.204.144.38/bitstreams/0b1a138e-db98-4751-9954-d4de203c71cb/download
http://18.204.144.38/bitstreams/41232259-5551-4025-9396-4ba6b7dd446e/download
bitstream.checksum.fl_str_mv a56361eef8eca62ffbbe84ac17ced2c1
8a4605be74aa9ea9d79846c1fba20a33
7210a811635d1799e7c05fee5d259be7
d03e281128eca501a5f914c7b4b026c2
df0081395a9c6dea5429acd61d4040a2
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv DSpace Pre-instalado Biteca S.A.S
repository.mail.fl_str_mv bibliotecas@biteca.com
_version_ 1814100676080304128
spelling Mendoza, NataliaDiamantis, MelissaArora, AnitaBartlett, BrendaGewirtzman, AronTremaine, Anne-MarieTyring, Stephen2020-11-11T20:11:59Z2020-11-11T20:11:59Z20081179-1888http://hdl.handle.net/20.500.12495/4677https://doi.org/10.2165/00128071-200809050-00003instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquehttps://repositorio.unbosque.edu.coapplication/pdfengSpringer LinkAmerican Journal of Clinical DermatologyAmerican Journal of Clinical Dermatology, 1179-1888, Vol. 9, Nro. 5, 2008 p. 295-305https://link.springer.com/article/10.2165/00128071-200809050-00003Mucocutaneous manifestations of Epstein-Barr virus infectionMucocutaneous manifestations of Epstein-Barr virus infectionArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85Síndrome mucocutáneo linfonodularEpstein-BarrInfeccionesThis review focuses on Epstein-Barr virus (EBV) infection, diagnosis, and current treatment, with emphasis on EBV-associated mucocutaneous manifestations in primary infections, acute EBV-associated syndromes, chronic infections, lymphoproliferative disorders, and lymphomas. In primary infection, EBV infects B cells and can cause mucocutaneous manifestations in infectious mononucleosis or acute EBV-associated syndromes such as Gianotti-Crosti syndrome and hemophagocytic syndrome. EBV then persists in the majority of humans generally without causing disease. In some cases, however, latent EBV infection may result in diseases such as hydroa vacciniforme, hypersensitivity to mosquito bites, and lymphoproliferative disorders such as plasmablastic lymphoma, oral hairy leukoplakia, and post-transplant lymphoproliferative disorders, particularly in immunocompromised patients. Latent EBV infection has also been implicated in a variety of malignant conditions such as Burkitt lymphoma, Hodgkin lymphoma, nasopharyngeal carcinoma, and Kikuchi histocytic necrotizing lymphadenitis. Since the immune system is critical in preventing the progression of EBV disease, the immunologic status of the patient plays a crucial role in the subsequent development of pathologies.Acceso abiertohttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2008ORIGINALMendoza_Natalia_2008.pdfMendoza_Natalia_2008.pdfapplication/pdf2267492http://18.204.144.38/bitstreams/8ef586ac-7162-4b4e-856b-6901da9e8908/downloada56361eef8eca62ffbbe84ac17ced2c1MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://18.204.144.38/bitstreams/cd8b509a-46cf-40ff-8265-a3139053ce3e/download8a4605be74aa9ea9d79846c1fba20a33MD52THUMBNAILGonzalez, L.V., Arango, A., López, J.P., Gnecco, J.P._2020.pdf (1).jpgGonzalez, L.V., Arango, A., López, J.P., Gnecco, J.P._2020.pdf (1).jpgimage/jpeg5775http://18.204.144.38/bitstreams/b77b26bc-93a9-4785-ad9f-479bb8f52b16/download7210a811635d1799e7c05fee5d259be7MD53Mendoza_Natalia_2008.pdf.jpgMendoza_Natalia_2008.pdf.jpgIM Thumbnailimage/jpeg9001http://18.204.144.38/bitstreams/0b1a138e-db98-4751-9954-d4de203c71cb/downloadd03e281128eca501a5f914c7b4b026c2MD54TEXTMendoza_Natalia_2008.pdf.txtMendoza_Natalia_2008.pdf.txtExtracted texttext/plain1424http://18.204.144.38/bitstreams/41232259-5551-4025-9396-4ba6b7dd446e/downloaddf0081395a9c6dea5429acd61d4040a2MD5520.500.12495/4677oai:18.204.144.38:20.500.12495/46772024-02-06 22:08:17.628restrictedhttp://18.204.144.38DSpace Pre-instalado Biteca S.A.Sbibliotecas@biteca.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